First-of-its-kind artificial heart valves

Researchers at the Murdoch Children's Research Institute in Melbourne have successfully produced the first three-dimensional human heart valve tissue using stem cells. This significant development greatly facilitates the advancement of heart tissue engineering, particularly in treating valve diseases that affect around 28 million people worldwide. These diseases can cause valve damage and impair their proper function, threatening patients' lives and sometimes making valve replacement necessary. The achievement aims to reduce the need for surgical valve replacements, which carry risks such as blood clots—especially in countries with limited healthcare resources. Additionally, it aids in testing and developing new treatments for valve diseases without risking patients' lives, through precise tissue models capable of adapting to the patient's body in the future.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل